Protagonist Therapeutics Inc at Barclays Global Healthcare Conference Transcript
Hello again everyone. I'm Etzer Darout, senior biotech analyst at Barclays. It's my pleasure to welcome Protagonist Therapeutics to our fireside. With me today, I have Dinesh Patel, the Chief Executive Officer and President at Protagonist.
Dinesh, maybe just to start off, for those maybe less familiar with the story, if you could just provide an overview of Protagonist, and then we'll move into Q&A.
Sounds like a plan. First and foremost, thanks for inviting us and I have to mention that this does take me down memory lane. Protagonist, we did our IPO back in 2016, and Barclays was one of the banks that helped us achieve that component of going public. So thanks for that as well to Barclays.
So yeah, right from the get go, we have focused on creating innovation through novel peptides. So that's our bread and butter, and we have expertise both for injectable peptides but also for oral peptides and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
